4.7 Article

How do providers of artificial intelligence (AI) solutions propose and legitimize the values of their solutions for supporting diagnostic radiology workflow? A technography study in 2021

Journal

EUROPEAN RADIOLOGY
Volume 33, Issue 2, Pages 915-924

Publisher

SPRINGER
DOI: 10.1007/s00330-022-09090-x

Keywords

Artificial intelligence; Radiology; Value proposition; Legitimization

Ask authors/readers for more resources

In the field of diagnostic radiology workflow, providers of AI solutions promote their products by proposing a variety of value propositions related to improving work efficiency and medical service quality, while using multiple strategies to legitimize and support these value propositions. However, these companies often provide limited evidence to show how their solutions deliver such systematic values in clinical practice.
Objectives How do providers of artificial intelligence (AI) solutions propose and legitimize the values of their solutions for supporting diagnostic radiology workflow? Methods We systematically analyze 393 AI applications developed for supporting diagnostic radiology workflow. We collected qualitative and quantitative data by analyzing around 1250 pages of documents retrieved from companies' websites and legal documents. Five investigators read and interpreted collected data, extracted the features and functionalities of the AI applications, and finally entered them into an excel file for identifying the patterns. Results Over the last 2 years, we see an increase in the number of AI applications (43%) and number of companies offering them (34%), as well as their average age (45%). Companies claim various value propositions related to increasing the efficiency of radiology work (18%)-e.g., via reducing the time and cost of performing tasks and reducing the work pressure-and quality of offering medical services (31%)-e.g., via enhancing the quality of clinical decisions and enhancing the quality of patient care, or both of them (28%). To legitimize and support their value propositions, the companies use multiple strategies simultaneously, particularly by seeking legal approvals (72%), promoting their partnership with medical and academic institutions (75%), highlighting the expertise of their teams (56%), and showcasing examples of implementing their solutions in practice (53%). Conclusions Although providers of AI applications claim a wide range of value propositions, they often provide limited evidence to show how their solutions deliver such systematic values in clinical practice.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available